Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lotus Pharmaceuticals Inc (LTUS)
OTHER OTC:LTUS
Lotus Pharmaceuticals (LTUS) Financial Statements
4 Followers
Lotus Pharmaceuticals Financial Overview
| Sep 11 | Jun 11 | Mar 11 | Dec 10 | Sep 10 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 19.04M | $ 18.69M | $ 12.92M | $ 20.73M | $ 18.30M |
| Gross Profit | $ 3.31M | $ 4.89M | $ 6.15M | $ 11.09M | $ 10.38M |
| EBIT | $ 1.32M | $ 1.84M | $ 2.30M | $ -3.72M | $ 6.96M |
| EBITDA | $ 1.73M | $ 2.25M | $ 2.70M | $ -2.81M | $ 7.41M |
| Net Income Common Stockholders | $ 1.25M | $ 1.77M | $ 2.24M | $ -3.53M | $ 6.70M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 158.91K | $ 886.45K | $ 1.31M | $ 1.34M | $ 897.65K |
| Total Assets | $ 120.16M | $ 114.49M | $ 107.75M | $ 103.18M | $ 103.83M |
| Total Debt | $ 5.41M | $ 5.36M | $ 5.28M | $ 5.24M | $ 5.17M |
| Net Debt | $ 5.25M | $ 4.48M | $ 3.96M | $ 3.90M | $ 4.28M |
| Total Liabilities | $ 20.70M | $ 17.24M | $ 13.82M | $ 14.16M | $ 12.94M |
| Stockholders Equity | $ 99.45M | $ 97.25M | $ 93.93M | $ 89.02M | $ 90.89M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -727.81K | $ -440.62K | $ -37.44K | $ 402.92K | $ -203.15K |
| Operating Cash Flow | $ 3.92M | $ 3.09M | $ 3.56M | $ 7.80M | $ 10.07M |
| Investing Cash Flow | $ -4.65M | $ -3.53M | $ -3.60M | $ -7.39M | $ -10.27M |
| Financing Cash Flow | $ 0.00 | - | - | - | $ 0.00 |
Lotus Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.